Maimon Carole Ben

Insider Reports History

Entity
Individual
Location
C/O Impax Laboratories, Inc., 30831 Huntwood Avenue, Hayward, CA
Signature
/s/ Jennifer Johansson, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Maimon Carole Ben:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Larimar Therapeutics, Inc. President and CEO, Director Common Stock 333K $1.24M $3.73 Jan 17, 2024 Direct
Larimar Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 397K Jan 17, 2024 Direct
Teligent, Inc. Director Restricted Stock Units 150K Jul 21, 2021 Direct

Insider Reports Filed by Maimon Carole Ben

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LRMR Larimar Therapeutics, Inc. Jan 17, 2024 2 $0 4 Jan 19, 2024 President and CEO, Director
LRMR Larimar Therapeutics, Inc. May 17, 2023 1 $18.5K 4 May 18, 2023 President and CEO, Director
LRMR Larimar Therapeutics, Inc. Jan 31, 2023 2 $0 4 Feb 2, 2023 President and CEO, Director
LRMR Larimar Therapeutics, Inc. Sep 16, 2022 1 $100K 4 Sep 19, 2022 President and CEO, Director
LRMR Larimar Therapeutics, Inc. May 10, 2022 1 $0 4 May 12, 2022 President and CEO, Director
LRMR Larimar Therapeutics, Inc. Jan 18, 2022 1 $0 4 Jan 20, 2022 President and CEO, Director
TLGT Teligent, Inc. Jul 21, 2021 1 $0 4 Jul 22, 2021 Director